A detailed history of Charles Schwab Investment Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 4,835,220 shares of LLY stock, worth $3.62 Billion. This represents 0.83% of its overall portfolio holdings.

Number of Shares
4,835,220
Previous 4,825,016 0.21%
Holding current value
$3.62 Billion
Previous $4.37 Billion 1.94%
% of portfolio
0.83%
Previous 0.84%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $7.88 Million - $9.8 Million
10,204 Added 0.21%
4,835,220 $4.28 Billion
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $109 Million - $137 Million
150,756 Added 3.23%
4,825,016 $4.37 Billion
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $67.3 Million - $90.1 Million
113,707 Added 2.49%
4,674,260 $3.64 Billion
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $65.8 Million - $77.5 Million
125,242 Added 2.82%
4,560,553 $2.66 Billion
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $38.3 Million - $52.7 Million
88,016 Added 2.02%
4,435,311 $2.38 Billion
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $11.7 Million - $15.6 Million
33,311 Added 0.77%
4,347,295 $2.04 Billion
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $9.89 Million - $11.6 Million
31,847 Added 0.74%
4,313,984 $1.48 Billion
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $24 Million - $28 Million
74,736 Added 1.78%
4,282,137 $1.57 Billion
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $110 Million - $125 Million
370,521 Added 9.66%
4,207,401 $1.36 Billion
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $9.03 Million - $10.6 Million
-32,394 Reduced 0.84%
3,836,880 $1.24 Billion
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $19.5 Million - $24.3 Million
83,299 Added 2.2%
3,869,274 $1.11 Billion
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $15.3 Million - $18.9 Million
67,876 Added 1.83%
3,785,975 $1.05 Billion
Q3 2021

Nov 16, 2021

BUY
$221.6 - $272.71 $11.6 Million - $14.3 Million
52,452 Added 1.43%
3,718,099 $859 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $14.4 Million - $18.6 Million
79,606 Added 2.22%
3,665,647 $841 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $499,697 - $646,881
-3,041 Reduced 0.08%
3,586,041 $670 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $1.28 Million - $1.69 Million
9,802 Added 0.27%
3,589,082 $606 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $45.3 Million - $52.4 Million
-309,768 Reduced 7.97%
3,579,280 $530 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $12.2 Million - $14.7 Million
89,685 Added 2.36%
3,889,048 $639 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $8.22 Million - $10.2 Million
-69,027 Reduced 1.78%
3,799,363 $527 Million
Q4 2019

Feb 07, 2020

SELL
$106.92 - $132.43 $4.96 Million - $6.14 Million
-46,369 Reduced 1.18%
3,868,390 $508 Million
Q3 2019

Nov 08, 2019

SELL
$106.79 - $116.16 $7.08 Million - $7.71 Million
-66,340 Reduced 1.67%
3,914,759 $438 Million
Q2 2019

Aug 09, 2019

SELL
$110.79 - $129.32 $10.6 Million - $12.4 Million
-95,911 Reduced 2.35%
3,981,099 $441 Million
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $1.99 Million - $2.34 Million
17,875 Added 0.44%
4,077,010 $529 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $631,481 - $707,450
-5,963 Reduced 0.15%
4,059,135 $470 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $10.5 Million - $13.1 Million
-122,303 Reduced 2.92%
4,065,098 $436 Million
Q2 2018

Aug 08, 2018

SELL
$75.7 - $86.88 $11.2 Million - $12.8 Million
-147,639 Reduced 3.41%
4,187,401 $357 Million
Q1 2018

May 07, 2018

BUY
$74.21 - $87.6 $6.34 Million - $7.49 Million
85,455 Added 2.01%
4,335,040 $335 Million
Q4 2017

Jan 17, 2018

BUY
$81.94 - $87.89 $11.1 Million - $11.9 Million
135,951 Added 3.3%
4,249,585 $359 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $317 Million - $352 Million
4,113,634
4,113,634 $352 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.